IGC
#4444
IGC Pharma, Inc. Common Stock
0.2 8 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
0.00%
Variación mensual
-3.45%
Variación en los últimos 6 meses
-4.96%
Cambio anual
+9.29%
Cierres anteriores
0.2 8
Open
0.2 8
Mínimo
0.2 8
Máximo
0.2 8
Volumen
36
Financials
- Market Capitalization 28.95 M
- Employee 70
- Founded 2005
- CEO N/A
- Website www.igcinc.us
- Headquarter Maryland, United States
- FIGI BBG000NSSLY8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.17
Relación precio/flujo de caja
17.16
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4431 |  QNCX Quince Therapeutics, Inc. - Common Stock | 29.55 USD | +2.04% | -7.31% | -5.71% | +1746.88% | 30.05 M USD | ||
| 4442 |  ESLA Estrella Immunopharma, Inc. - Common Stock | 0.67 USD | 0.00% | +4.69% | -6.94% | -38.53% | 29.14 M USD | ||
| 4448 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.69 USD | 0.00% | -14.65% | -51.58% | -82.23% | 28.61 M USD | ||
| 4464 |  CVM Cel-Sci Corporation Common Stock | 1.50 USD | -1.32% | -10.18% | +0.67% | -70.87% | 26.38 M USD |